HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Volume 20, No. 8, August 2016 – Novel Technologies for Antibody Drug Discovery in Japan       » Global Experts Convene to Discuss China's Plan for Diabetes Prevention and Rehabilitation in 2016       » Butterflies Offer Climate Scientists Ecological Insights       » Thermal Stability of Camelid Single Domain VHH Antibody       » That Gut Feeling: How A Healthy Digestive System Has Everything To Do With It       » World Heart Day - At the Heart of Health      
Volume 20, Number 08, August 2016
Novel Technologies for Antibody Drug Discovery in Japan
Display of Membrane Proteins on a Viral Envelope for Antibody Generation
Membrane proteins are a major drug target in cancer immunotherapy
Enhancement of the Stability of Single Chain Fv Molecules with the Amino Acid Substitutions Predicted by High-Performance Computer
A single chain variable fragment (scFv) is a kind of fusion protein keeping the function of immunoglobulin
A Cascade of Protein Aggregation Bombards Mitochondria for Neurodegeneration and Apoptosis under WWOX Deficiency
Tumor suppressor WW domain-containing oxidoreductase...
Antibody Solution Viscosity and Intermolecular Interactions: Considerations for Development of Highly Concentrated Formulations
A dramatic increase in the demand for highly concentrated antibody formulations...
MEDNIVA Develops New Science-based Teaching Method for Healthcare Industry
MEDNIVA provides learning solutions to cater to the healthcare industry worldwide...
Cover
Volume 20 (2016) Number 06 (June)
FEATURES  
High-Throughput Sequencing on a Next Generation Sequencer to Identify Specific Binders from a Phage Library
In recent decades, many antibody therapeutics have been developed for the clinical treatment of cancer, auto immune diseases, and infectious diseases. Initially, these antibodies were mainly developed by the humanization of murine antibodies produced by hybridomas. Although new technologies for producing human antibodies, such as trans-chromo mice with human immunoglobulin loci and...
Antibody Solution Viscosity and Intermolecular Interactions: Considerations for Development of Highly Concentrated Formulations
In recent years, a dramatic increase in the demand for highly concentrated antibody formulations have been observed...
Display of Membrane Proteins on a Viral Envelope for Antibody Generation
Membrane proteins are a major drug target in cancer immunotherapy...
SPOTLIGHTS  
New Discovery: Interleukin-25 Induced by Q2-3 to Suppress Tumour Metastasis
We followed up with Dr. Shu-Yi Yin, the first author of the article to learn more about the research. Dr. Shu-Yi Yin is a postdoctoral fellow at the Agricultural Biotechnology Research Centre, Academic Sinica...
MEDNIVA Develops New Science-based Teaching Method for Healthcare Industry
MEDNIVA provides learning solutions to cater to the healthcare industry worldwide...
EYE ON CHINA  
Pfizer Advances Biosimilars Leadership with Investment in a New World-Class Global Biotechnology Center in China
Pfizer's state-of-the-art facility will foster the continued development of the biotechnology industry in China, further supporting National healthcare reforms
Global Experts Convene to Discuss China's Plan for Diabetes Prevention and Rehabilitation in 2016
Synthace Awarded Technology Pioneer by World Economic Forum
INSIDE INDUSTRY  
Asia's Medical Technology Start-ups Get New Fast Track to Market via Partnership between Cambridge Consultants and Clearbridge Accelerator Mitsubishi Electric and Sembcorp Industries to Testbed Novel Ozone Backwashing Energy-Saving Membrane Bioreactor LEO Pharma Enters Biologics through Strategic Partnership with AstraZeneca
BIOBOARD  
New Way of Looking at Cancer
Clusters of circulating cells commonly found in the blood of cancer patients have long been the subject of research on cancer. These clusters have been regarded for more than 50 years as malignant cells that have broken off from the primary tumor, spreading cancer to other parts of the body.
Novel Discovery by NUS Scientists Improves Profiling of AML Patients for Targeted Therapies 56
New Biomaterial Developed for Injectable Neuronal Control
Improving Agricultural Yield and Quality through Tissue Culture Technology
A Cascade of Protein Aggregation Bombards Mitochondria for Neurodegeneration and Apoptosis under WWOX Deficiency
NEWS CRUNCH  
news CPhI's Pre-Connect Congress outlines current trends in pharma
news World Population Day 2016
news NUS Student Clinches Top Prize at National Smart Mapping Competition with Cutting-Edge Food Security Solution
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2016
January:
Guest Editorial - Biotechnology In Korea
February:
Guest Editorial - Biomedical Research Governance
March:
Guest Editorial - Life-Saving Opportunities: A Guide to Regenerative Medicine
April:
Leading-Edge ONCOLOGY
May:
Healthcare Systems & Policies in Asia
June:
Medical Devices & Healthcare Technology
July:
Water Technology and Management
August:
Novel Technologies for Antibody Drug Discovery in Japan
September:
Infectious Diseases
October:
Medical Tourism
November:
Big Data in Healthcare
December:
Evidence-based TCM
Editorial calendar is subjected to changes.
– Editor: Carmen, Jia Wen Loh
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com or Mr Edward
Copyright© 2016 World Scientific Publishing Co Pte Ltd  •  Privacy Policy